OT mobile menu

Search form


Caroline Robert, MD, PhD

Caroline Robert, MD, PhD

Posts by Author

In this video we discuss 3-year overall survival data from the KEYNOTE-001 trial, which studied the anti–PD-1 antibody pembrolizumab in patients with advanced melanoma.

By clicking Accept, you agree to become a member of the UBM Medica Community.